According to Orchard Therapeutics 's latest financial reports the company's current revenue (TTM) is $21.83 M. In 2022 the company made a revenue of $22.65 M an increase over the years 2021 revenue that were of $1.67 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $21.83 M | -3.6% |
2022 | $22.65 M | 1252.54% |
2021 | $1.67 M | -35.45% |
2020 | $2.59 M | 3.26% |
2019 | $2.51 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Organovo ONVO | $0.24 M | -98.89% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $21.83 M | 0.00% | ๐ฌ๐ง UK |
Novavax NVAX | $0.69 B | 3,075.33% | ๐บ๐ธ USA |
Novocure
NVCR | $0.50 B | 2,232.24% | Jersey |